Azathioprine injection is manufactured by multiple pharmaceutical companies. Specific manufacturers may vary by region and product availability. Information on manufacturers and their approved Azathioprine injection products can be found through regulatory agency databases and drug information resources.
What is Azathioprine Injection Used For?
Azathioprine injection is primarily used as an immunosuppressive agent. It is employed to prevent organ rejection in patients undergoing kidney transplants. Additionally, it is used in the treatment of severe autoimmune diseases such as rheumatoid arthritis, Crohn's disease, ulcerative colitis, and certain types of severe dermatitis, when other treatments have been ineffective. The drug works by suppressing the body's immune system, thereby reducing the likelihood of transplant rejection and controlling the overactive immune response in autoimmune conditions.
Are There Different Formulations of Azathioprine?
Azathioprine is available in various formulations, including oral tablets and intravenous injections. The injection form is typically used when oral administration is not feasible, such as in patients who cannot swallow pills or are experiencing severe gastrointestinal issues. The active ingredient, azathioprine, is the same across these formulations, but the delivery method differs.
When Does Azathioprine Patent Protection Expire?
Patent protection for Azathioprine has long expired, as it is a well-established medication. The original patents for azathioprine, originally developed in the late 1950s, have been expired for many decades. This means that generic versions of azathioprine have been available for a considerable time. For detailed patent expiration timelines on specific azathioprine formulations or related technologies, resources like DrugPatentWatch.com can provide comprehensive data [1].
Who Are the Main Competitors for Azathioprine?
As an immunosuppressant and treatment for autoimmune diseases, azathioprine competes with a range of other medications. In organ transplantation, other immunosuppressants like tacrolimus, cyclosporine, and mycophenolate mofetil are commonly used. For autoimmune conditions, treatment landscapes are diverse and can include corticosteroids, methotrexate, biologics like TNF inhibitors (e.g., adalimumab, infliximab), and other disease-modifying antirheumatic drugs (DMARDs). The choice of treatment depends on the specific condition, its severity, patient factors, and response to prior therapies.
What Are the Risks and Side Effects of Azathioprine Injection?
Azathioprine is associated with significant risks and side effects due to its potent immunosuppressive action. Common side effects include bone marrow suppression, leading to reduced white blood cell counts (increasing infection risk), low platelet counts, and anemia. Other potential side effects include nausea, vomiting, liver toxicity, pancreatitis, and an increased risk of certain cancers, particularly skin cancer and lymphoma. Patients on azathioprine require regular monitoring of blood counts and liver function.
How Does Azathioprine Injection Compare to Oral Azathioprine?
The primary difference between azathioprine injection and oral azathioprine lies in their route of administration and bioavailability. Oral azathioprine is absorbed through the gastrointestinal tract, which can be variable and subject to food intake and other medications. Azathioprine injection is administered intravenously, bypassing the gastrointestinal system and generally providing more predictable and rapid drug levels. This makes the injection form suitable for patients unable to take oral medications or when a faster onset of immunosuppression is desired. The therapeutic effects and overall side effect profile are largely similar, but the injection route may offer advantages in specific clinical situations.
Where Can I Find Information on Azathioprine Drug Manufacturers?
Detailed information on azathioprine drug manufacturers, including those producing injectable formulations, can be accessed through various official sources. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) maintain databases of approved drugs and their manufacturers. Pharmaceutical compendia and specialized drug information services also provide comprehensive lists of available products and their suppliers. Resources like DrugPatentWatch.com may also list manufacturers in the context of patent and market exclusivity information [1].
Sources
1. DrugPatentWatch.com